Birdwatch Archive

Birdwatch Note Rating

2024-08-14 09:51:00 UTC - NOT_HELPFUL

Rated by Participant: E299079E4695D1A79E0B173C849BB0B1282C1137079FC4963BBB23DA1DF7F8CA
Participant Details

Original Note:

The scholarly articles have report "...These results suggest that a third dose of BNT162b2 is safe, improves humoral immunity against SARS-CoV-2, and could be immunologically beneficial for cancer patients on active chemotherapy." : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004706/ A scientific study is needed NOT speculation

All Note Details

Original Tweet

All Information

  • noteId - 1823488630217957579
  • participantId -
  • raterParticipantId - E299079E4695D1A79E0B173C849BB0B1282C1137079FC4963BBB23DA1DF7F8CA
  • createdAtMillis - 1723629060073
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1823488630217957579E299079E4695D1A79E0B173C849BB0B1282C1137079FC4963BBB23DA1DF7F8CA